Yu, M., Wang, C., Lee, M., Ou, H., Cheng, P., Tu, S., . . . Huang, C. (2023). TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetesConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statements. Elsevier.
Chicago Style (17th ed.) CitationYu, Ming-Lung, et al. TASL, TADE, and DAROC Consensus for the Screening and Management of Hepatitis C in Patients with DiabetesConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus Statements. Elsevier, 2023.
MLA (9th ed.) CitationYu, Ming-Lung, et al. TASL, TADE, and DAROC Consensus for the Screening and Management of Hepatitis C in Patients with DiabetesConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus StatementsConsensus Statements. Elsevier, 2023.